Hayat Pharmaceutical Industries Co (AMM:HPIC) Short-Term Debt: JOD1.21 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

AMM:HPIC Hayat Pharmaceutical Industries Co AMM:HPIC
49 GF Score
Price JOD3.26
! 9 Warning Signs
View Full Analysis

What is Hayat Pharmaceutical Industries Co Short-Term Debt?

Hayat Pharmaceutical Industries Co AMM:HPIC +1.87% 49 Short-Term Debt is JOD1.21 Mil as of Mar. 2026. GuruFocus rates AMM:HPIC with a GF Score™ of 49/100. The stock has 9 warning signs investors should review.

Hayat Pharmaceutical Industries Co's Short-Term Debt for the quarter that ended in Mar. 2026 was JOD1.21 Mil.

Hayat Pharmaceutical Industries Co's quarterly Short-Term Debt declined from Sep. 2025 (JOD1.40 Mil) to Dec. 2025 (JOD1.00 Mil) but then increased from Dec. 2025 (JOD1.00 Mil) to Mar. 2026 (JOD1.21 Mil).

Hayat Pharmaceutical Industries Co's annual Short-Term Debt increased from Dec. 2023 (JOD0.48 Mil) to Dec. 2024 (JOD0.54 Mil) and increased from Dec. 2024 (JOD0.54 Mil) to Dec. 2025 (JOD1.00 Mil).

Hayat Pharmaceutical Industries Co Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Hayat Pharmaceutical Industries Co Short-Term Debt Related Terms

Hayat Pharmaceutical Industries Co Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Hayat Pharmaceutical Industries Co's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hayat Pharmaceutical Industries Co Short-Term Debt Chart

Hayat Pharmaceutical Industries Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.27 1.16 0.48 0.54 1.00

Hayat Pharmaceutical Industries Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.58 1.40 1.00 1.21
AMM:HPIC
49GF Score
Hayat Pharmaceutical Industries Co AMM:HPIC
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of JOD1.21 Mil mean?
Hayat Pharmaceutical Industries Co (AMM:HPIC) has a Short-Term Debt of JOD1.21 Mil as of Mar. 2026.
Is Hayat Pharmaceutical Industries Co's Short-Term Debt too high?
Hayat Pharmaceutical Industries Co's current Short-Term Debt is JOD1.21 Mil. Overall, Hayat Pharmaceutical Industries Co has a GF Score™ of 49/100, reflecting its overall financial health beyond just this single metric.
How does Hayat Pharmaceutical Industries Co's Short-Term Debt compare to ZTS and UTHR?
Hayat Pharmaceutical Industries Co's Short-Term Debt of JOD1.21 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Drug Manufacturers company?
A good Short-Term Debt depends on the Drug Manufacturers industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Hayat Pharmaceutical Industries Co's current Short-Term Debt is JOD1.21 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hayat Pharmaceutical Industries Co stock overvalued right now?
Hayat Pharmaceutical Industries Co (AMM:HPIC) has a current Short-Term Debt of JOD1.21 Mil. The current Short-Term Debt is JOD1.21 Mil. Hayat Pharmaceutical Industries Co's overall GF Score™ is 49/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Hayat Pharmaceutical Industries Co (AMM:HPIC), the current Short-Term Debt is JOD1.21 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Hayat Pharmaceutical Industries Co Business Description

Address Mohammed Ali Alkurdi St. Al-Rajeeb Amman, 1564 Amman, Amman, JOR, 11118
Hayat Pharmaceutical Industries Co is a Jordan based pharmaceutical manufacturing company. The princapal activity is producing human and veterinary medicines in all its forms and medical stickers and stockings, in addition to the production of medical supplies, body care lotions, cosmetics, sutures and initiating marketing campgains as well as import and export operations. Its products include Cardiovascular system, Infectious disease, Dermatology, Gastrointestinal system, Inner Ear & Balance, Men's Health, Neurology, Vitamins & Supplements, Women's Health, and Respiratory system. The operations business operating within one geographic sector which is the Hashemite Kingdom of Jordan.
49GF Score

Get the complete analysis for AMM:HPIC

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

JOD3.26
Price